HomeStock ScreenerAmrutanjan Health Care

Amrutanjan Health Care Share Price | Amrutanjan Health Care Stock Screener

AMRUTANJAN Pharmaceuticals
Share Price NSE
₹519.80
▼ -9.30 (-1.76%)
2026-07-23 00:00:00
Share Price BSE
₹518.15
▼ -11.20 (-2.12%)
2026-07-23 00:00:00
As of July 23, 2026, the Amrutanjan Health Care share price (NSE: AMRUTANJAN) is ₹519.80 on NSE and ₹518.15 on BSE, down 1.76% from the previous close, with shares trading between ₹517.00 and ₹531.10, and a 52-week range of ₹493.65–₹767.65. Analyse Amrutanjan Health Care stock price data download and track historical price performance. Use the Amrutanjan Health Care stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Amrutanjan Health Care Market Cap ₹1,529.66 Cr.
AMRUTANJAN P/E Ratio (TTM) -
Amrutanjan Health Care P/B Ratio 4.20
EPS (TTM) ₹14.08
Dividend Yield 0.91%
Debt to Equity 0.02
AMRUTANJAN 52 Week High ₹767.65
Amrutanjan Health Care 52 Week Low ₹493.65
Operating Margin -
Profit Margin -
AMRUTANJAN Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹140.00
Total Equity ₹109.00

Amrutanjan Health Care Share Price Chart

Screen Amrutanjan Health Care share price with an interactive chart. Analyse AMRUTANJAN price trends and volatility across different timeframes.

Amrutanjan Health Care Company Profile - Fundamental Screener

Screen Amrutanjan Health Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AMRUTANJAN shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE098F01031

Amrutanjan Health Care Balance Sheet Screener

Screen AMRUTANJAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2016 2015
Assets
Total Assets 140 124
Current Assets 101 83
Fixed Assets 29 24
Liabilities
Total Liabilities 0 0
Current Liabilities 4 3
Non-Current Liabilities 0 0
Shareholders' Equity
Total Equity 109 95
Share Capital 3 3
Reserves & Surplus 106 92

Amrutanjan Health Care Income Statement Screener - Profit & Revenue Analysis

Screen Amrutanjan Health Care income statement and profit fundamentals. Analyze AMRUTANJAN quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Amrutanjan Health Care share price evaluation.
Item None-None 2016-March 2015-March
Revenue 0 192 171
Expenses 0 156 143
EBITDA 0 37 28
Operating Profit % 0.00% 16.00% 14.00%
Depreciation 0 3 3
Interest 0 0 1
Profit Before Tax 0 32 24
Tax 0 12 9
Net Profit 0 21 15
EPS 0.00 14.08 10.31

Amrutanjan Health Care Cash Flow Screener - Liquidity Fundamentals

Screen AMRUTANJAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2016-March 2015-March
Operating Activities 21 18
Investing Activities 4 -5
Financing Activities -13 -12
Net Cash Flow 12 2

Amrutanjan Health Care Shareholding Pattern Screener

See Amrutanjan Health Care shareholding pattern with promoter, FII, and DII holdings. Check Amrutanjan Health Care promoter holding and ownership changes for AMRUTANJAN on TickJournal.
Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun
Promoter Holding 46.52% 46.52% 46.52% 46.52% 46.52% 46.52% 50.59% 50.59%
FII Holding 2.17% 2.44% 2.30% 2.41% 2.38% 2.27% 1.38% 1.55%
DII Holding 12.66% 12.28% 11.41% 12.70% 12.90% 13.00% 7.29% 7.32%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 32.20% 32.06% 33.56% 32.28% 32.18% 32.09% 34.17% 33.87%
Other Holding 6.45% 6.70% 6.22% 6.09% 6.02% 6.13% 6.57% 6.67%
Shareholder Count 45,805 45,135 51,674 49,431 47,954 46,675 62,664 57,169

Amrutanjan Health Care Share Dividend Screener - Share Yield Analysis

Check Amrutanjan Health Care dividend history with payout and yield data. View Amrutanjan Health Care dividend details including ex-dates and amounts for AMRUTANJAN stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹4.60 0.93%
2024-March ₹4.60 0.71%
2023-March ₹4.60 0.74%
2022-March ₹4.60 0.80%
2021-March ₹4.20 0.53%
2020-March ₹2.10 0.37%
2019-March ₹2.15 0.65%
2018-March ₹3.05 0.99%
2017-March ₹3.85 1.42%

Amrutanjan Health Care Stock Index Membership

See which indices include Amrutanjan Health Care stock. Check AMRUTANJAN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Amrutanjan Health Care is not part of any tracked indices.
Only major market indices are tracked in our system.

Amrutanjan Health Care Market Events Screener - Corporate Actions

Get Amrutanjan Health Care corporate actions including splits, bonuses, and buybacks. Check Amrutanjan Health Care stock events that may affect AMRUTANJAN share price.
Announcement Date Record Date Event Type Information Price Impact
2026-05-08 2026-05-08 Quarterly Result Announcement NA -3.93%
2026-02-06 2026-02-07 Dividend ₹ 1.00 /share 10.34%
2026-02-03 2026-02-03 Quarterly Result Announcement NA -2.77%
2025-11-18 2025-11-18 Dividend ₹ 1.00 /share 0.36%
2025-11-10 2025-11-10 Quarterly Result Announcement NA -1.32%
2025-09-23 2025-09-23 Annual General Meeting NA 15.67%
2025-09-16 2025-09-16 Dividend ₹ 2.60 /share 6.32%
2025-08-12 2025-08-12 Quarterly Result Announcement NA -4.43%
2025-05-15 2025-05-15 Quarterly Result Announcement NA 5.45%
2025-02-18 2025-02-18 Dividend ₹ 1.00 /share -4.60%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -5.10%
2024-11-22 2024-11-22 Dividend ₹ 1.00 /share 0.77%
2024-11-12 2024-11-12 Quarterly Result Announcement NA -8.10%
2024-09-23 2024-09-23 Annual General Meeting NA 5.89%
2024-09-13 2024-09-17 Dividend ₹ 2.60 /share 7.69%

Amrutanjan Health Care Competitors Screener - Peer Comparison

Screen AMRUTANJAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 466,191 40.90 61,674 12.69% 11,565 61.52
Divis Laboratories 196,088 75.78 11,067 13.95% 2,568 73.60
Torrent Pharmaceuticals 191,454 79.75 13,886 20.34% 2,138 66.10
Cipla 114,318 29.97 29,045 2.24% 3,870 47.02
Zydus Life Science 113,332 22.27 27,658 17.64% 5,026 51.92
Lupin 110,051 21.47 29,039 26.75% 5,356 47.81
Mankind Pharma 105,095 54.93 14,636 14.85% 1,938 55.85
Dr Reddys Laboratories 98,725 24.22 35,059 3.90% 4,158 29.50
Aurobindo Pharma 88,240 26.21 33,385 3.21% 3,376 49.50
Laurus Labs 85,179 96.66 6,868 22.01% 890 64.23

Amrutanjan Health Care Company Announcements - News Screener

Screen AMRUTANJAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-07-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-24 Closure of Trading Window -
2026-06-19 Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot -
2026-06-19 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-05-28 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-27 Reconstitution Of Committees Of Board Of Directors. -
2026-05-26 Announcement under Regulation 30 (LODR)-Change in Management -
2026-05-19 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot -
2026-05-18 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot -
2026-05-13 Financial Results - Machine Readable Format -
2026-05-09 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-05-08 Intimation On Rolling Out Of The Revised Second Phase ESOP 2 Of The Existing ESOP Scheme Of The Company By The Name Of Amrutanjan Health Care Limited - Employees Stock Option Scheme 2020. -
2026-05-08 Announcement under Regulation 30 (LODR)-Change in Management -
2026-05-08 Announcement under Regulation 30 (LODR)-Change in Management -
2026-05-08 Board Meeting Outcome for Outcome Of Board Meeting -
2026-04-30 Board Meeting Intimation for Board Meeting Intimation For Audited Financial Results For The Quarter And Year Ended 31 March 2026 Recommendation Of Final Dividend For The Year 2025-26 -
2026-04-17 Product Launch -
2026-04-17 Rephrasing Of ESOP -
2026-04-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-24 Closure of Trading Window -